共 31 条
Treating Clostridium difficile Infection With Fecal Microbiota Transplantation
被引:749
作者:
Bakken, Johan S.
[1
]
Borody, Thomas
Brandt, Lawrence J.
[2
]
Brill, Joel V.
[3
]
Demarco, Daniel C.
[4
]
Franzos, Marc Alaric
[5
]
Kelly, Colleen
[6
]
Khoruts, Alexander
[7
,8
]
Louie, Thomas
[9
]
Martinelli, Lawrence P.
[13
]
Moore, Thomas A.
[10
]
Russell, George
[11
]
Surawicz, Christina
[12
]
机构:
[1] St Lukes Infect Dis Associates, Duluth, MN USA
[2] Albert Einstein Coll Med, Montefiore Med Ctr, Div Gastroenterol, New York, NY USA
[3] Predict Hlth LLC, Phoenix, AZ USA
[4] Baylor Univ, Med Ctr, Dallas, TX USA
[5] Marine Aircraft Grp 24, Kaneohe Bay, HI USA
[6] Brown Univ, Women & Infants Hosp, Providence, RI USA
[7] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[8] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA
[9] Univ Calgary, Calgary, AB T2N 1N4, Canada
[10] Ochsner Hlth Syst, Dept Infect Dis, New Orleans, LA USA
[11] Massachusetts Gen Hosp Children, Boston, MA USA
[12] Univ Washington, Sch Med, Dept Med, Div Gastroenterol, Seattle, WA 98195 USA
[13] Consultants Infect Dis, Lubbock, TX USA
关键词:
Clostridium difficile;
Transplantation;
Microbiota;
Fecal Enema;
Recurrent Infection;
Diarrhea;
PLACEBO-CONTROLLED TRIAL;
SACCHAROMYCES-BOULARDII;
TREATMENT STRATEGIES;
CASE SERIES;
DISEASE;
DIARRHEA;
EPIDEMIOLOGY;
ENTEROCOLITIS;
VANCOMYCIN;
SEVERITY;
D O I:
10.1016/j.cgh.2011.08.014
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Clostridium difficile infection is increasing in incidence, severity, and mortality. Treatment options are limited and appear to be losing efficacy. Recurrent disease is especially challenging; extended treatment with oral vancomycin is becoming increasingly common but is expensive. Fecal microbiota transplantation is safe, inexpensive, and effective; according to case and small series reports, about 90% of patients are cured. We discuss the rationale, methods, and use of fecal microbiota transplantation.
引用
收藏
页码:1044 / 1049
页数:6
相关论文